Full Length Research Paper
References
Australian Bureau of Statistics (2013). Statistics. |
||||
Awadalla P, Gauthier J, Myers RA, Casals F, Hamdan FF, Griffing AR, Côté M, Henrion E, Spiegelman D, Tarabeux J, Piton A, Yang Y, Boyko A, Bustamante C, Xiong L, Rapoport JL, Addington AM, DeLisi JL, Krebs MO, Joober R, Millet B, Fombonne E, Mottron L, Zilversmit M, Keebler J, Daoud H, Marineau C, Roy-Gagnon MH, Dubé MP, Eyre-Walker A, Drapeau P, Stone EA, Lafrenière RG, Rouleau GA (2010). Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am. J. Hum. Genet. 87: 316-324. Crossref |
||||
Cavagnaro AT (2003). Autistic Spectrum Disorders. Changes in California Caseload. An Update: 1999 through 2002. California Health and Human Services Agency. PubMed |
||||
Centers for Disease Control (1989). Measles--United States, first 26 weeks. MMWR;38:863-6. PubMed |
||||
Centers of Disease Control and Prevention (2012a). Vital Statistics of the United States. Available: |
||||
Centers of Disease Control and Prevention (2012b). Vital Statistics Data - Births. |
||||
Centers of Disease Control and Prevention (2012d). U.S. Vaccination Coverage Reported via NIS. |
||||
Centers of Disease Control and Prevention (2012c). National vital Statistics System. Available: |
||||
De Ligt J WM, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE (2012). Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367:1921-1929. Crossref |
||||
Frank O, Zheng C, Hehlmann R, Leib-Mösch C, Seifarth W (2005). Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J. Virol. 79:10890-10901. Crossref |
||||
Freimanis G, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG, Nelson PN (2010). A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investiga-ting mechanisms of pathogenesis. Clin. Exp. Immunol. 160:340-347. Crossref |
||||
Girard SL GJ, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, Thibodeau P, Bachand I, Bao JY, Tong AH, Lin CH, Millet B, Jaafari N, Joober R, Dion PA, Lok S, Krebs MO, Rouleau GA (2011) Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43:860-863. Crossref |
||||
Individuals with Disabilities Education Act (IDEA) (2012). Child Count Data. |
||||
Kaye JA dMM-MM, Jick H (2001). Mumps, measles, and rubella vac-cine and the incidence of autism recorded by general practitioners:a time trend analysis. BMJ 322:460-463. | ||||
Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, Steinberg S, Helgason H, Thorleifsson G, Gudbjartsson DF, Helgason A, Magnusson OT, Thorsteinsdottir U, Stefansson K (2012). Rate of de novo mutations and the importance of father's age to disease risk. Nature 488:471-475. Crossref |
||||
Kurth R (1998). Risk potential of the chromosomal insertion of foreign DNA. Dev. Biol Stand. 93: 45-56. PubMed |
||||
Lauritsen M, Pedersen C, Mortensen P (2004). The incidence and prevalence of pervasive developmental disorders: a Danish populationbased 34:3391346. | ||||
Leibenluft ERB (2008). Pediatric bipolar disorder. Ann. Rev Clin. Psychol. 4:163-187. Crossref |
||||
Lingam R, Simmons R, Andrews A, Miller N, Stowe E, Taylor B (2002). Prevalence of autism and parentally reported triggers in a North east London population. Arch. Dis. Childhood 888(8):666-670. | ||||
Lord C, Risi S, Di Lavore PS, Shulman C, Thurm A, Pickles A (2006). Autism From 2 to 9 Years of Age. Arch. Gen. Psychiatry 63:694-701. Crossref |
||||
Luo R SS, Tian Y, Voineagu I, Huang N, Chu SH, Klei L, Cai C, Ou J, Lowe JK, Hurles ME, Devlin B, State MW, Geschwind DH. (2012). Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am. J. Hum. Genet. 91:38-55. Crossref |
||||
Luyster R, Gotham K, Guthrie W, Coffing M, Petrak R, Pierce K, Bishop S, Esler A, Hus V, Oti R, Richler J, Risi S, Lord C (2009). The Autism Diagnostic Observation Schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J. Autism Dev. Disord. 39:1305-1320. Crossref |
||||
McDonald ME PJ (2010). Timing of increased autistic disorder cumulative incidence. Environ. Sci. Technol. 44: 2112-2118. Crossref |
||||
Merck O (2011). Summary Basis for Approval Varivax. US Dept HHS FDA Vaccines, Blood and Biologics. |
||||
Muggeo VM (2008). Segmented: an R Package to Fit Regression Models with Broken-Line Relationships. R. News pp. 20-25. | ||||
Nassar N DG, Bourke J, Bower C, Glasson E, de Klerk N, Leonard H (2009). Autism and Intellectual Disability are Differentially Related to Sociodemographic Background at Birth. Int. J. Epidemiol. 38: 1245-1254. Crossref |
||||
Newschaffer CJ FM, Gurney JG (2005). National autism prevalence trends from United States special education data. Pediatrics 115:277-282. Crossref |
||||
Oker-Blim C,Ulmanen I, Kaariainen L, Pettersson R (1984). Rubella Virus 40S Genome RNA Specifies a 24S Subgenomic mRNA That Codes for a Precursor to Structural Proteins. J. Virol. 49(2):403-408. | ||||
Okkels NVD, Jensen SO, McGrath JJ, Nielsen RE (2012). Changes in the diagnosed incidence of early onset schizophrenia over four decades. Acta Psychiatr. Scand. 127(1):62-68. Crossref |
||||
O'Roak BJ DP, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE (2011). Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat. Genet. 43:585-589. Crossref |
||||
Qian S (2010). Environmental and Ecological Statistics with R. Boca Raton, FL: Chapman & Hall/CRC. | ||||
Robinson P (2010). Whole-exome sequencing for finding de novo mutations in sporadic mental retardation. Genome Biol. 11:144-146. Crossref |
||||
Sakamoto Y, Ishiguro M, Kitagawa G (1986). Akaike Information Criterion Statistics: D. Reidel Publishing Company. | ||||
Schechter R, Grether JK (2008). Continuing increases in autism reported to California's developmental services system: mercury in retrograde. Arch. Gen. Psychiatry 65:19-24. Crossref |
||||
Tai AK, Alroy KA, Simon KC, Munger KL, Huber BT, Ascherio A (2008). Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult. Scler. 14:1175-1180. Crossref |
||||
Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J (1999). Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353(9169):2026-2029. Crossref |
||||
Tiwari RCK, Davis W, Feuer E, Yu B, Chib S (2005). Bayesian model selection for join point regression with application to age-adjusted cancer rates. Appl. Stat. 54:919–939. Crossref |
||||
Treffert D (1970). Epidemiology of infantile autism. Arch. Gen. Psychiatry 22: 431-438. Crossref |
||||
US Food and Drug Administration (2011). Summary Basis for Approval Varivax. |
||||
US Census Bureau (2012a). Population Estimates. |
||||
US Census Bureau (2012b). American Fact Finder. |
||||
Van Den Bossche MJ, Strazisar M, Pickard BS, Goossens D, Lenaerts AS, De Zutter S, Nordin A, Norrback KF, Mendlewicz J, Souery D, De Rijk P, Sabbe BG, Adolfsson R, Blackwood D, Del-Favero J (2012). Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not? Am. J. Med. Genet. B. Neuropsychiatr. Genet. 159B:812-822. Crossref |
||||
Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, Gardner S, Delwart EL (2010). Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J. Virol. 84:6033-6040. Crossref |
||||
Wiggins LD, Baio J, Rice C (2006). Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. J. Dev. Behav. Pediatr. 27(2 Suppl):S79-87. Crossref |
||||
Wikipedia (2014a). Retrieved from Measles Virus: |
||||
Wikipedia. (2014b). Retrieved from Mumps Virus: |
||||
Wikipedia. (2014c). Retrieved from Viral Hepatitis: |
||||
Xu B I-LI, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA, Karayiorgou M (2012). De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 44:1365-1369. Crossref |
||||
Yolken RH, Yee F, Johnston-Wilson NL, Torrey EF (2000). Endogenous retroviruses and schizophrenia. Brain Res. Brain Res. Rev. 31:193-199. Crossref |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0